Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 1
1978 1
1979 1
1980 3
1981 1
1982 5
1984 1
1985 2
1986 5
1987 1
1988 2
1989 6
1990 11
1991 12
1992 13
1993 13
1994 7
1995 11
1996 7
1997 5
1998 13
1999 9
2000 13
2001 6
2002 10
2003 8
2004 12
2005 10
2006 13
2007 9
2008 13
2009 9
2010 4
2011 5
2012 6
2013 3
2014 5
2015 7
2016 5
2017 6
2018 8
2019 5
2020 6
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

283 results
Results by year
Filters applied: . Clear all
Page 1
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Colhoun HM, et al. Among authors: durrington pn. Lancet. 2004 Aug 21-27;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5. Lancet. 2004. PMID: 15325833 Clinical Trial.
Diabetic dyslipidaemia.
Soran H, Schofield JD, Adam S, Durrington PN. Soran H, et al. Among authors: durrington pn. Curr Opin Lipidol. 2016 Aug;27(4):313-22. doi: 10.1097/MOL.0000000000000318. Curr Opin Lipidol. 2016. PMID: 27213628 Review.
HDL functionality.
Soran H, Hama S, Yadav R, Durrington PN. Soran H, et al. Among authors: durrington pn. Curr Opin Lipidol. 2012 Aug;23(4):353-66. doi: 10.1097/MOL.0b013e328355ca25. Curr Opin Lipidol. 2012. PMID: 22732521 Review.
Antioxidant properties of HDL.
Soran H, Schofield JD, Durrington PN. Soran H, et al. Among authors: durrington pn. Front Pharmacol. 2015 Oct 16;6:222. doi: 10.3389/fphar.2015.00222. eCollection 2015. Front Pharmacol. 2015. PMID: 26528181 Free PMC article. Review.
Hypercholesterolaemia and its management.
Bhatnagar D, Soran H, Durrington PN. Bhatnagar D, et al. Among authors: durrington pn. BMJ. 2008 Aug 21;337:a993. doi: 10.1136/bmj.a993. BMJ. 2008. PMID: 18719012 Review. No abstract available.
Lipoprotein (a): gene genie.
Durrington PN, Schofield JD, Siahmansur T, Soran H. Durrington PN, et al. Curr Opin Lipidol. 2014 Aug;25(4):289-96. doi: 10.1097/MOL.0000000000000096. Curr Opin Lipidol. 2014. PMID: 24977982 Review.
Editorial introduction.
Durrington PN. Durrington PN. Curr Opin Lipidol. 2017 Aug;28(4):v. doi: 10.1097/MOL.0000000000000439. Curr Opin Lipidol. 2017. PMID: 28700378 No abstract available.
Secondary hyperlipidaemia.
Durrington PN. Durrington PN. Br Med Bull. 1990 Oct;46(4):1005-24. doi: 10.1093/oxfordjournals.bmb.a072438. Br Med Bull. 1990. PMID: 2100685 Review.
Lipoprotein (a).
Durrington PN. Durrington PN. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):773-95. doi: 10.1016/s0950-351x(95)80145-6. Baillieres Clin Endocrinol Metab. 1995. PMID: 8593125 Review.
Evidence for more intensive cholesterol lowering.
Soran H, Kwok S, Adam S, Ho JH, Durrington PN. Soran H, et al. Among authors: durrington pn. Curr Opin Lipidol. 2017 Aug;28(4):291-299. doi: 10.1097/MOL.0000000000000433. Curr Opin Lipidol. 2017. PMID: 28509674 Review.
283 results